Identification of Biomarkers for the Prevention of Chronic Disease

S Boccia, Jun Liu, Ayse Demirkan, Cornelia Duijn, M Mariani, C Castagna, R Pastorino, S Fiatal, P Pikó, R Ádány, G Bottà

Research output: Chapter/Conference proceedingChapterAcademic

1 Citation (Scopus)


One of the goals of personalised medicine (PM) is to use the ever-growing understanding of biology to provide a higher level of precision in disease prevention and patient care. PM strategies include the use of decision-making processes based on biomarker-driven approaches. Genes, gene expression products (i.e. transcripts and proteins) and metabolites are the main biomarker families. Given this molecular diversity of biomarkers, the increase in high-throughput omics technologies offers an amazing opportunity to capture the whole picture of biological systems in a hypothesis-free and unbiased model. This chapter examines as the high-throughput era in omics is progressing and as genomics and other omics will be effective in disentangling the aetiology and progression of the diseases.

Original languageEnglish
Title of host publicationPersonalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact
EditorsS. Boccia, R. Adany, P. Villari, M. C. Cornel, C. de Vito, R. Pastorino
Place of PublicationSpringer
Publisher[uitgever onbekend]
Number of pages9
ISBN (Print)9783030523985
Publication statusPublished - 2021

Publication series

SeriesSpringerBriefs in Public Health

Bibliographical note

Export Date: 24 January 2021


Dive into the research topics of 'Identification of Biomarkers for the Prevention of Chronic Disease'. Together they form a unique fingerprint.

Cite this